Posted Jan. 24, 2014 at 12:33 p.m.

Premium Lock Pain drug from BDSI shows positive trial results, triggers $10M milestone

Published: 2014-01-24 12:33:50
Updated: 2014-01-24 12:33:50


Chronic pain drug BEMA buprenorphine showed positive top-line phase III clinical trial results, and securing trial data for further analysis has triggered a $10 million milestone to BioDelivery Sciences International....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders